152 related articles for article (PubMed ID: 11386415)
1. Differential expression of somatostatin receptors in medulloblastoma.
Guyotat J; Champier J; Pierre GS; Jouvet A; Bret P; Brisson C; Belin MF; Signorelli F; Montange MF
J Neurooncol; 2001 Jan; 51(2):93-103. PubMed ID: 11386415
[TBL] [Abstract][Full Text] [Related]
2. High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: implications for diagnosis and therapy.
Frühwald MC; O'Dorisio MS; Pietsch T; Reubi JC
Pediatr Res; 1999 May; 45(5 Pt 1):697-708. PubMed ID: 10231868
[TBL] [Abstract][Full Text] [Related]
3. Comparison of somatostatin receptor expression in human gliomas and medulloblastomas.
Cervera P; Videau C; Viollet C; Petrucci C; Lacombe J; Winsky-Sommerer R; Csaba Z; Helboe L; Daumas-Duport C; Reubi JC; Epelbaum J
J Neuroendocrinol; 2002 Jun; 14(6):458-71. PubMed ID: 12047721
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of somatostatin receptors in ependymoma: implications for diagnosis.
Guyotat J; Champier J; Jouvet A; Signorelli F; Houzard C; Bret P; Saint Pierre G; Fevre Montange M
Int J Cancer; 2001 May; 95(3):144-51. PubMed ID: 11307146
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin expression in medulloblastomas and medulloblastoma cell lines.
Albrecht S; Bayer TA; Kraus JA; Pietsch T
Neuropathol Appl Neurobiol; 1995 Oct; 21(5):399-409. PubMed ID: 8632835
[TBL] [Abstract][Full Text] [Related]
6. [Examination of somatostatin receptor expression in recurrent childhood medulloblastomas].
Kaszper E; Hanzély Z; Szende B; Dabasi G; Garami M; Schuler D; Hauser P
Magy Onkol; 2008 Dec; 52(4):351-5. PubMed ID: 19068462
[TBL] [Abstract][Full Text] [Related]
7. Analysis of somatostatin receptor subtype mRNA expression in human breast cancer.
Evans AA; Crook T; Laws SA; Gough AC; Royle GT; Primrose JN
Br J Cancer; 1997; 75(6):798-803. PubMed ID: 9062398
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
Phi JH; Kim JH; Eun KM; Wang KC; Park KH; Choi SA; Kim YY; Park SH; Cho BK; Kim SK
J Neurosurg Pediatr; 2010 Jun; 5(6):608-14. PubMed ID: 20515335
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor 2 expression in the human endometrium through the menstrual cycle.
Green VL; Richmond I; Maguiness S; Robinson J; Helboe L; Adams IP; Drummond NS; Atkin SL
Clin Endocrinol (Oxf); 2002 May; 56(5):609-14. PubMed ID: 12030911
[TBL] [Abstract][Full Text] [Related]
10. Medulloblastoma comprises four distinct molecular variants.
Northcott PA; Korshunov A; Witt H; Hielscher T; Eberhart CG; Mack S; Bouffet E; Clifford SC; Hawkins CE; French P; Rutka JT; Pfister S; Taylor MD
J Clin Oncol; 2011 Apr; 29(11):1408-14. PubMed ID: 20823417
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of somatostatin receptors, P44/42 MAPK, and mTOR activation in medulloblastomas and primitive neuroectodermal tumors.
Johnson MD; O'Connell MJ; Silberstein H; Korones D
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):532-8. PubMed ID: 23455179
[TBL] [Abstract][Full Text] [Related]
12. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma.
Remke M; Hering E; Gerber NU; Kool M; Sturm D; Rickert CH; Gerß J; Schulz S; Hielscher T; Hasselblatt M; Jeibmann A; Hans V; Ramaswamy V; Taylor MD; Pietsch T; Rutkowski S; Korshunov A; Monoranu CM; Frühwald MC
Childs Nerv Syst; 2013 Aug; 29(8):1253-62. PubMed ID: 23677175
[TBL] [Abstract][Full Text] [Related]
14. SGNE1/7B2 is epigenetically altered and transcriptionally downregulated in human medulloblastomas.
Waha A; Koch A; Hartmann W; Milde U; Felsberg J; Hübner A; Mikeska T; Goodyer CG; Sörensen N; Lindberg I; Wiestler OD; Pietsch T; Waha A
Oncogene; 2007 Aug; 26(38):5662-8. PubMed ID: 17334394
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
16. Evidence for Somatostatin receptor 2 in thyroid tissue.
Druckenthaner M; Schwarzer C; Ensinger C; Gabriel M; Prommegger R; Riccabona G; Decristoforo C
Regul Pept; 2007 Jan; 138(1):32-9. PubMed ID: 16996150
[TBL] [Abstract][Full Text] [Related]
17. Expression of somatostatin type-2 and -4 receptor and correlation with histological type in breast cancer.
Frati A; Rouzier R; Lesieur B; Werkoff G; Antoine M; Rodenas A; Darai E; Chereau E
Anticancer Res; 2014 Aug; 34(8):3997-4003. PubMed ID: 25075022
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of survivin splice isoforms in medulloblastomas.
Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
[TBL] [Abstract][Full Text] [Related]
19. Expression of somatostatin receptors 3, 4, and 5 in mouse kidney proximal tubules.
Bates CM; Kegg H; Petrevski C; Grady S
Kidney Int; 2003 Jan; 63(1):53-63. PubMed ID: 12472768
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]